A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars
- PMID: 30993303
- DOI: 10.7417/CT.2019.2116
A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars
Abstract
Objective: To investigate the therapeutic effect of CBD-ointment administered on severe skin chronic diseases and/or on their outcome scars.
Methods: A spontaneous, anecdotal, retrospective study of 20 patients with two most frequent skin disorders: psoriasis (n: 5 patients), atopic dermatitis (n: 5) and resulting outcome scars (n: 10). The subjects were instructed to administer topical CBD-enriched ointment to lesioned skin areas twice daily for three months treatment.
Results: Based on skin evaluations (hydration, TEWL, elasticity), clinical questionnaires (SCORAD, ADI, PASI), and supported by photographic data and investigators' clinical assessment, the results showed that topical treatment with CBD-enriched ointment significantly improved the skin parameters, the symptoms and also the PASI index score. No irritant or allergic reactions were documented during the period treatment.
Conclusions: The topical administration of CBD ointment, without any THC, is a safe and effective non-invasive alternative for improve the quality of life in patients with some skin disorders, especially on inflammatory background.
Keywords: CBD; Ointment; Quality of life; Skin.
Similar articles
-
Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis.J Dtsch Dermatol Ges. 2013 May;11(5):437-43. doi: 10.1111/ddg.12074. Epub 2013 Apr 2. J Dtsch Dermatol Ges. 2013. PMID: 23551950 Clinical Trial.
-
Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.Am J Clin Dermatol. 2001;2(6):389-406. doi: 10.2165/00128071-200102060-00005. Am J Clin Dermatol. 2001. PMID: 11770393 Review.
-
Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.J Am Acad Dermatol. 2009 Feb;60(2):212-7. doi: 10.1016/j.jaad.2008.09.034. Epub 2008 Nov 22. J Am Acad Dermatol. 2009. PMID: 19027990 Clinical Trial.
-
Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.Clin Exp Allergy. 2004 Apr;34(4):639-45. doi: 10.1111/j.1365-2222.2004.1907.x. Clin Exp Allergy. 2004. PMID: 15080819 Clinical Trial.
-
Topical tacrolimus for atopic dermatitis.Cochrane Database Syst Rev. 2015 Jul 1;2015(7):CD009864. doi: 10.1002/14651858.CD009864.pub2. Cochrane Database Syst Rev. 2015. PMID: 26132597 Free PMC article. Review.
Cited by 24 articles
-
Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.Mol Cell Biochem. 2022 Mar 29. doi: 10.1007/s11010-022-04417-0. Online ahead of print. Mol Cell Biochem. 2022. PMID: 35348980 Review.
-
Cannabinoids: Therapeutic Use in Clinical Practice.Int J Mol Sci. 2022 Mar 19;23(6):3344. doi: 10.3390/ijms23063344. Int J Mol Sci. 2022. PMID: 35328765 Free PMC article. Review.
-
A Single-Center Study Evaluating the Effects of a Novel Retinol and Cannabidiol Combination Topical on Facial Skin.Aesthet Surg J Open Forum. 2022 Jan 27;4:ojac002. doi: 10.1093/asjof/ojac002. eCollection 2022. Aesthet Surg J Open Forum. 2022. PMID: 35274096 Free PMC article.
-
The Transdermal Delivery of Therapeutic Cannabinoids.Pharmaceutics. 2022 Feb 18;14(2):438. doi: 10.3390/pharmaceutics14020438. Pharmaceutics. 2022. PMID: 35214170 Free PMC article. Review.
-
Cannabinoids for the Treatment of Dermatologic Conditions.JID Innov. 2022 Jan 13;2(2):100095. doi: 10.1016/j.xjidi.2022.100095. eCollection 2022 Mar. JID Innov. 2022. PMID: 35199092 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
